Living EuroGuiDerm Guideline for the systemic treatment of psoriasis vulgaris
The European Dermatology Forum published a guideline for the systemic treatment of psoriasis vulgaris. The recommendations in the guideline are based on the Living Cochrane review published in January 2020. As new evidence continues to become available, the guidelines will be updated as necessary. Recommendations for co-morbidities will also be addressed in future updates.
In addition to contributing to the development process, IFPA created a patient-facing checklist to accompany the medical recommendations.
To find more on the European Guidelines for Chronic Plaque Psoriasis, join the IFPA Webinar Series June 3rd 2021.